Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2017
Unifying mechanism for different fibrotic diseasesGerlinde Wernig, Shih-Yu Chen, Lu Cui, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
A multi-omics map of diabetic nephropathy reveals c-Jun as a driver of tubular injury and metabolic stressQiwen Deng, Yu Liu, Nathan A Bracey, et al.
Kidney International Reports|September 22, 2025
The Immune Microenvironment of Transplant GlomerulitisNathan A Bracey, Jonathan S Maltzman, Adrienne H Long, et al.
Blood|June 29, 2006
JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation modelThomas Mercher, Gerlinde Wernig, Sandra A Moore, et al.
Annals of Surgery|December 27, 2018
Doxycycline Reduces Scar Thickness and Improves Collagen ArchitectureAlessandra L Moore, Heather E desJardins-Park, Bryan A Duoto, et al.
Nature Communications|February 8, 2019
Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservationAgnieszka Czechowicz, Rahul Palchaudhuri, Amelia Scheck, et al.
Blood|January 25, 2008
The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenesGerlinde Wernig, Jeffrey R Gonneville, Brian J Crowley, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2021
Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitorsLu Cui, Ignacio Moraga, Tristan Lerbs, et al.
Cancer Research|November 15, 2012
STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2Winnie F Tam, Patricia S Hähnel, Andrea Schüler, et al.
Cancer Cell|June 15, 2010
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cellsAnn Mullally, Steven W Lane, Brian Ball, et al.
Pageof 4